Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Regeneron Pharmaceuticals Inc. pages available for free this week:
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Enterprise Value (EV)
- Price to FCFE (P/FCFE)
- Selected Financial Data since 2005
- Operating Profit Margin since 2005
- Debt to Equity since 2005
- Total Asset Turnover since 2005
- Price to Earnings (P/E) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Regeneron Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Regeneron Pharmaceuticals Inc., consolidated balance sheet: assets (quarterly data)
US$ in thousands
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
Over the observed period, the company’s total assets exhibited a general upward trend, although with some fluctuations. Initial growth from March 2021 to June 2021 was substantial, followed by a period of more moderate increases and some quarterly declines before resuming a stronger growth trajectory in late 2023 and into 2025. A significant portion of this asset growth is attributable to increases in both current and noncurrent asset categories.
- Cash and Cash Equivalents
- Cash and cash equivalents demonstrated considerable volatility. A peak was observed in September 2021, followed by a decrease, and then another increase reaching a high in March 2023. Subsequently, a decline occurred, with fluctuations continuing through December 2025. This suggests active cash management, potentially related to investment activities, acquisitions, or operational needs.
- Marketable Securities
- Marketable securities generally increased over the period, with a notable acceleration in growth from March 2022 onwards. This indicates a strategic shift towards holding more liquid investments, potentially to capitalize on market opportunities or to provide a buffer for future expenditures. The increase from 2024 to 2025 is particularly pronounced.
- Accounts Receivable, Net
- Accounts receivable remained relatively stable, fluctuating between approximately US$4.8 billion and US$6.2 billion. A slight upward trend is discernible, suggesting consistent sales activity. The consistency in this figure indicates effective credit and collection policies.
- Inventories
- Inventories exhibited a consistent, albeit gradual, upward trend throughout the period. This increase could be attributed to anticipated demand, production efficiencies, or changes in inventory management strategies. The growth from 2023 to 2025 is more pronounced than earlier periods.
- Current Assets
- Current assets experienced significant growth from March 2021 to December 2021, followed by continued, though less dramatic, increases. Fluctuations were observed, but the overall trend remained positive. The composition of current assets, as detailed above, significantly influenced this overall trend.
- Noncurrent Assets
- Noncurrent assets demonstrated a consistent upward trend, with substantial growth observed from 2021 through 2025. This growth was driven primarily by increases in marketable securities, property, plant, and equipment, and deferred tax assets. The increase in intangible assets, while starting later, also contributed to this trend.
- Property, Plant, and Equipment, Net
- Property, plant, and equipment, net, showed a steady increase over the period, indicating ongoing investment in long-term assets. This suggests a commitment to expanding operational capacity or upgrading existing infrastructure.
- Intangible Assets, Net
- Intangible assets began to be reported in September 2022 and exhibited consistent growth through December 2025. This suggests investments in intellectual property, patents, or other intangible resources, potentially related to research and development activities.
- Deferred Tax Assets
- Deferred tax assets increased substantially throughout the period, indicating a growing ability to utilize tax benefits in the future. This growth is likely linked to the company’s profitability and tax planning strategies.
In summary, the asset base of the company expanded considerably over the analyzed timeframe. The growth was fueled by increases in both current and noncurrent assets, with marketable securities and deferred tax assets contributing significantly to the overall expansion. The fluctuations in cash and cash equivalents suggest active financial management, while the consistent growth in property, plant, and equipment and intangible assets indicates a long-term investment strategy.